
    
      It is a randomized, single-center, open-label, category A clinical trial, a research project
      on people involved in the collection of biological material and the collection of
      health-related personal data with the existence of consent.

      The investigators will study the effectiveness of Betadine subcutaneous tissue disinfection
      during primary shoulder surgery. They will randomize 105 patient on two arms. The control
      group receiving no disinfection of the subcutaneous tissue (A) and intervention group,
      receiving disinfection of the subcutaneous tissue (B). The investigators estimate that 4
      years is enough to recruit the number of patients needed for this study.

      All patients 18 years of age or older admitted to the Valais Hospital to receive primary
      shoulder surgery and who have signed the consent of the study will be eligible.
    
  